Chernett Jorey sold $4.5M of STIM
Chernett Jorey sold 3,335,411 shares of Neuronetics, Inc. (STIM) at an average of $1.34 ($1.15–$2.39, $4.48M total) across 5 trades over 2026-11-06 to 2026-11-13.
How this was made
The 30-second read
Why it matters
The disclosed sale adds immediate sell‑side pressure and may prompt short‑term price decline.
Market read
Primary insider sale of a mid‑cap biotech, likely to cause short‑term downward movement.
What to watch
Potential tax planning or diversification needs of the insider.
Background
Neuronetics (NASDAQ:STIM) develops transcranial magnetic stimulation devices for treatment‑resistant depression. Insider sales are disclosed via Form 4 filings.
Ticker impact
10% owner Chernett Jorey sold 3.33M shares (~$4.5M) in open‑market transactions, reducing holdings to 7.33M shares.
downward pressure as the market prices in the insider sell.
The sale represents a significant portion of the insider's stake and is disclosed via a Form 4, a primary source filing.
Market effects
May weigh on the neurotechnology/psychiatric device sector as investors watch insider sentiment.
Limited to U.S. markets where STIM trades.
Low; impact confined to the specific stock.
Counterpoint
The sale could be a routine liquidity event unrelated to company fundamentals.
Key entities
- InsiderChernett Jorey
10% owner of Neuronetics who sold shares.
- CompanyNeuronetics, Inc.
Developer of TMS medical devices.

